Healthcare Ventures Ix, L.p. - Net Worth and Insider Trading

Healthcare Ventures Ix, L.p. Net Worth

The estimated net worth of Healthcare Ventures Ix, L.p. is at least $1 Million dollars as of 2024-11-13. Healthcare Ventures Ix, L.p. is the 10% Owner of Leap Therapeutics Inc and owns about 414,480 shares of Leap Therapeutics Inc (LPTX) stock worth over $1 Million. Details can be seen in Healthcare Ventures Ix, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Healthcare Ventures Ix, L.p. has not made any transactions after 2019-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Healthcare Ventures Ix, L.p.

To

Healthcare Ventures Ix, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Healthcare Ventures Ix, L.p. owns 1 companies in total, including Leap Therapeutics Inc (LPTX) .

Click here to see the complete history of Healthcare Ventures Ix, L.p.’s form 4 insider trades.

Insider Ownership Summary of Healthcare Ventures Ix, L.p.

Ticker Comapny Transaction Date Type of Owner
LPTX Leap Therapeutics Inc 2019-02-05 10 percent owner

Healthcare Ventures Ix, L.p. Latest Holdings Summary

Healthcare Ventures Ix, L.p. currently owns a total of 1 stock. Healthcare Ventures Ix, L.p. owns 414,480 shares of Leap Therapeutics Inc (LPTX) as of February 5, 2019, with a value of $1 Million.

Latest Holdings of Healthcare Ventures Ix, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LPTX Leap Therapeutics Inc 2019-02-05 414,480 3.25 1,347,060

Holding Weightings of Healthcare Ventures Ix, L.p.


Healthcare Ventures Ix, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Healthcare Ventures Ix, L.p. has made a total of 0 transactions in Leap Therapeutics Inc (LPTX) over the past 5 years. The most-recent trade in Leap Therapeutics Inc is the acquisition of 57,143 shares on February 5, 2019, which cost Healthcare Ventures Ix, L.p. around $999,999.

Insider Trading History of Healthcare Ventures Ix, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Healthcare Ventures Ix, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Healthcare Ventures Ix, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Healthcare Ventures Ix, L.p. is 13.8%. GuruFocus also compares Healthcare Ventures Ix, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Healthcare Ventures Ix, L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Healthcare Ventures Ix, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Healthcare Ventures Ix, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.14 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.77 LIMIT LIMIT LIMIT LIMIT LIMIT

Healthcare Ventures Ix, L.p. Ownership Network

Ownership Network List of Healthcare Ventures Ix, L.p.

No Data

Ownership Network Relation of Healthcare Ventures Ix, L.p.

Insider Network Chart

Healthcare Ventures Ix, L.p. Owned Company Details

What does Leap Therapeutics Inc do?

Who are the key executives at Leap Therapeutics Inc?

Healthcare Ventures Ix, L.p. is the 10 percent owner of Leap Therapeutics Inc. Other key executives at Leap Therapeutics Inc include Chief Scientific Officer Jason Baum , 10 percent owner Beigene, Ltd. , and VP & Head of Reg Affairs/Qual Christine Granfield .

Leap Therapeutics Inc (LPTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Leap Therapeutics Inc Insider Transactions

No Available Data

Healthcare Ventures Ix, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Healthcare Ventures Ix, L.p.. You might contact Healthcare Ventures Ix, L.p. via mailing address: 55 Cambridge Parkway, Suite 102, Cambridge Ma 02142.